• 1
    Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32: 10251033.
  • 2
    Kontos HA, Shapiro W, Mauck HP, Patterson JL. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964; 37: 526535.
  • 3
    Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM, Cobos MA, Rodriguez-Eire JL, Garcia-Plaza A. et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 1989; 97: 13041312.
  • 4
    Lewis FW, Adair O, Rector WG Jr. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102: 10241029.
  • 5
    Rector WG Jr, Adair O, Hossack KF, Rainguet S. Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor. Gastroenterology 1990; 99: 766770.
  • 6
    Bernardi M, Marco CD, Trevisani F, Collibus CD, Fornale L, Baraldini M, Andreone P, et al. The hemodynamic status of preascitic cirrhosis: An evaluation under steady-state conditions and after postural change. Hepatology 1992; 16: 341346.
  • 7
    Azoulay D, Casting D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19: 129132.
  • 8
    Braillon A, Lee SS, Girod C, Peignoux-Martinot M, Valla D, Lebrec D. Role of portosystemic shunts in hyperkinetic circulation of the portal hypertensive rat. J Lab Clin Med 1986; 108: 543548.
  • 9
    Lee SS, Johansen K, Lebrec D. Circulatory changes induced by portal venous diversion and mesenteric hypertension in rats. Hepatology 1992; 15: 117121.
  • 10
    Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role of nitric oxide? Lancet 1991; 337: 776778.
  • 11
    Marietta MA, Poksyn SY, Lyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 87068711.
  • 12
    Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18: 11391143.
  • 13
    Albillos A, Rossi I, Cacho G, Martínez MV, Millán I, Abreu L, Barrios C. et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995; 268: G459G464.
  • 14
    Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213218.
  • 15
    Colman J. Portal venous pressure (PVP) falls with time in patients with alcoholic cirrhosis [Abstract]. Hepatology 1988; 12: 1244A.
  • 16
    Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 1984; 4: 424429.
  • 17
    Caesar J, Shaldon S, Chiandushi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 4357.
  • 18
    Hori N, Takahashi H, Okanoue T, Sawa Y, Mori T, Takami S, Yoshimura M. et al. Augmented endogenous nitric oxide production in partial portal vein-ligated rats. J Hepatol 1995; 22: 250251.
  • 19
    Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 20022012.
  • 20
    Wennmalm A, Benthin G, Edlund A, Jungersen L, Kieler-Jensen N, Lundin S, Westfelt UN, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993; 73: 11211127.
  • 21
    Okumura H, Aramaki T, Katsuta Y, Satomura K, Akaike M, Sekiyama T, Terada H. et al. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites. Am J Gastroenterol 1991; 86: 4652.
  • 22
    Guyton AC. Cardiac output, venous return, and their regulation. In: GuytonAC. ed. Textbook of medical physiology. Ed 6. Philadelphia: Saunders, 1986: 272286.
  • 23
    Ohkubo H, Okuda K, Lida S, Ohnishi K, Ikawa S, Makino I. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. Gastroenterology 1984; 86: 514520.
  • 24
    Schrier RW, Caramela C. Hemodynamic and hormonal alterations in hepatic cirrhosis. In: EpsteinM. ed. The kidney in liver disease. Ed 3. Baltimore: Williams &Wilkins, 1988: 265285.
  • 25
    Whittle BJR, Moncada S. Nitric oxide: The elusive mediator of the hyperdynamic circulation of cirrhosis? Hepatology 1992; 16: 10891092.
  • 26
    Shijo H, Sasaki H, Miyajima Y, Okumura M. Prostaglandin F2α and indo-methacin on hepatogenic pulmonary angiodysplasia: effects on pulmonary hemodynamics and gas exchange. Chest 1991; 100: 873875.
  • 27
    Guarner C, Soriano G, Such J, Teixido M, Ramis I, Bulbena O, Roselló J, et al. Systemic prostacyclin in cirrhotic patients: relationship with portal hypertension and changes after intestinal decontamination. Gastroenterology 1992; 102: 303309.
  • 28
    Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992; 263: G149G154.
  • 29
    Tesfamariam B, Cohen RA. Inhibition of adrenergic vasoconstriction by endothelial cell shear stress. Circ Res 1988; 63: 720725.
  • 30
    Rubanyi GM, Freay AD, Kauser K, Johns A, Harder DR. Mechanoreception by the endothelium: mediators and mechanisms of pressure-and flowinduced vascular responses. Blood Vessels 1990; 27: 246257.
  • 31
    Sigmon DH, Crretero OA, Beierwaltes WH. Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 263: F256F261.
  • 32
    Simmons JC, Freeman RH. L-arginine analogues inhibit aldosterone secretion in rats. Am J Physiol 1995; 268: R1137R1142.
  • 33
    Bosch J, Arroyo V, Betriu A, Mas A, Carriho F, Rivera F, Navarro-Lopez F. et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 9299.
  • 34
    Lumsden AB, Henderson JM, Kunter MH. Endotoxin levels measured by chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8: 232236.
  • 35
    Toyonaga A, Iwao T, Sumino M, Oho K, Ikegami M, Sakai M, Shigemori H. et al. Portal pressure after prophylactic sclerotherapy in patients with high-risk varices. J Hepatol 1994; 21: 515520.
  • 36
    Poimer-Layrargues G, Kusielewicz D, Willems B, Villeneuve JP, Marleau D, Cǒté J, Huet PH. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology 1985; 5: 415418.
  • 37
    Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 1986; 6: 287298.
  • 38
    Henderson JM, Mackay GJ, Lumsden AB, Atta HM, Brouillard R, Kunter MH. The effects of liver denervation on hepatic hemodynamics during hypovolemic shock in swine. Hepatology 1992; 15: 130133.